- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04571346
Female Sling Procedure
A Two Paramedian Vaginal Incisions Versus the Standard Longitudinal Incision of Trans-Obturator Tape Procedure for Management of Urinary Incontinence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
the investigator innovated a new technique that involves a 2 paramedian vaginal incisions that allow more tape stabilization with sparing the dissection along the whole urethra ensuring intact overlying tissues and to create a tunnel in between the 2 incisions to pass the tape, making it supported proximally and distally with normal undissected tissues.
the study aims to assess the success rate of TOT and tape migration using a new surgical technique versus the standard procedure using vertical incision.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adult female patient complaining of pure stress incontinence confirmed by stress test of urodynamic study
Exclusion Criteria:
- Patients with neurological disease, pelvic organ prolapse, previous urethral or pelvic floor surgery will be excluded from our study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: the classical TOT procedure
performing the trans-obturator procedure through the standard vertical incision
|
TOT procedure will be done using silicon-coated polypropylene tape that will be inserted at the mid-urethral portion.
In group 1, a classical vertical vaginal incision will be done proximal to the external urethral meatus with dissection along the axis of the urethra till the mid-urethral zone that is identified by palpating the urethral catheter balloon through the vaginal at the bladder neck, while in group 2, two paramedian incisions will be done 1cm long in the anterior vaginal wall 2 cm apart parallel to the urethra till identification of the mid-urethral portion, communication will be done between the two incisions 1 cm wide in this area creating a tunnel where the tape will be placed, this technique provides healthy tissues proximal and distal to the tape that allows more stabilization and less migration.
The rest of the procedure is the same as the standard procedure of Trans-obturator outside-in tension-free technique.
|
Experimental: 2 paramedian vertical incisions
performing the trans-obturator procedure through a new technique of 2 paramedian vertical incisions
|
TOT procedure will be done using silicon-coated polypropylene tape that will be inserted at the mid-urethral portion.
In group 1, a classical vertical vaginal incision will be done proximal to the external urethral meatus with dissection along the axis of the urethra till the mid-urethral zone that is identified by palpating the urethral catheter balloon through the vaginal at the bladder neck, while in group 2, two paramedian incisions will be done 1cm long in the anterior vaginal wall 2 cm apart parallel to the urethra till identification of the mid-urethral portion, communication will be done between the two incisions 1 cm wide in this area creating a tunnel where the tape will be placed, this technique provides healthy tissues proximal and distal to the tape that allows more stabilization and less migration.
The rest of the procedure is the same as the standard procedure of Trans-obturator outside-in tension-free technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
tape migration
Time Frame: to be evaluated at 3rd month postoperative
|
to evaluate TOT migration postoperative from the middle third of the urethra by trans-labial ultrasound
|
to be evaluated at 3rd month postoperative
|
tape migration
Time Frame: to be evaluated at 6th month postoperative
|
to evaluate TOT migration postoperative from the middle third of the urethra by trans-labial ultrasound
|
to be evaluated at 6th month postoperative
|
tape migration
Time Frame: to be evaluated at12th month postoperative
|
to evaluate TOT migration postoperative from the middle third of the urethra by trans-labial ultrasound
|
to be evaluated at12th month postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
continence after surgery
Time Frame: to be evaluated at 3,6 and 12 month postoperative
|
to evaluate success rate in treatment of stress urinary incontinence using stress cough test and urodynamic study
|
to be evaluated at 3,6 and 12 month postoperative
|
de-novo urgency
Time Frame: to be evaluated at 12 month postoperative
|
appearance of urgency incontinence from patient symptomology evaluation whether present or not
|
to be evaluated at 12 month postoperative
|
vaginal erosion
Time Frame: to be evaluated up to 1 year post operative
|
postoperative complication of TOT where vagina erosion may occur, (yes/no)
|
to be evaluated up to 1 year post operative
|
urine retention
Time Frame: to be evaluated in the first 24 hours postoperative
|
postoperative complication of TOT ( present or not)
|
to be evaluated in the first 24 hours postoperative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU R51/2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence,Stress
-
University of New MexicoRecruitingUrinary Incontinence | Urge Incontinence | Stress Incontinence, FemaleUnited States
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
Clinical Trials on trans-obturator procedure
-
Al-Mustafa University CollegeAl-Sadr Teaching HospitalCompletedStress Urinary IncontinenceIraq
-
Ain Shams Maternity HospitalCompletedMed: Urinary Incontinence (Stress, Urge, Mixed)
-
University of ManitobaUnknownStress Urinary Incontinence | Urethral Sling SurgeryCanada
-
Brno University HospitalCompletedUrinary Incontinence, Stress
-
Ain Shams UniversityCompleted
-
Newcastle-upon-Tyne Hospitals NHS TrustCompletedUrinary Incontinence | Stress
-
Coordinación de Investigación en Salud, MexicoUnknownStress Urinary IncontinenceMexico
-
Cairo UniversityCompleted
-
Kasr El Aini HospitalCompletedStress Urinary IncontinenceEgypt
-
Cairo UniversityCompleted